Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Yimin Duan"'
Autor:
Lin Zhang, Jingkun Qu, Yutao Qi, Yimin Duan, Yu-Wen Huang, Zhifen Zhou, Ping Li, Jun Yao, Beibei Huang, Shuxing Zhang, Dihua Yu
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
Breast cancer cells are known to metastasize to the bone but why the cells should migrate and metastasize to this particular organ is not clearly understood. Here, the authors show that EZH2 activates an integrin B1 and FAK signaling pathway in breas
Externí odkaz:
https://doaj.org/article/05aa232c6afd450daf8510c54d82f59b
Publikováno v:
Hangkong bingqi, Vol 31, Iss 3, Pp 51-58 (2024)
Cooperative search is a future development direction in the field of cruise missile multi-projectile control, and its research is helpful for cruise missile to adapt to the future battlefield intelligent operation requirements. To solve the problem o
Externí odkaz:
https://doaj.org/article/61ea2b50a9b1468ca4196084599417fb
Autor:
Dihua Yu, John A. Tainer, Jenny C. Chang, Shao-Cong Sun, Haoqiang Ying, Wen-Ling Kuo, Xianghua Liu, Yohei Saito, Akosua Badu-Nkansah, Chenyu Zhang, Ping Li, Arseniy E. Yuzhalin, Lin Zhang, Hongzhong Li, Jun Yao, Davide Moiani, Zamal Ahmed, Yuan Zhang, Yutao Qi, Kai Sun, Yi Xiao, Yimin Duan, Xiangliang Yuan
Supplementary Data from Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::154bc5981696651ae8cde6a89bc4e522
https://doi.org/10.1158/2159-8290.22541254
https://doi.org/10.1158/2159-8290.22541254
Autor:
Dihua Yu, John A. Tainer, Jenny C. Chang, Shao-Cong Sun, Haoqiang Ying, Wen-Ling Kuo, Xianghua Liu, Yohei Saito, Akosua Badu-Nkansah, Chenyu Zhang, Ping Li, Arseniy E. Yuzhalin, Lin Zhang, Hongzhong Li, Jun Yao, Davide Moiani, Zamal Ahmed, Yuan Zhang, Yutao Qi, Kai Sun, Yi Xiao, Yimin Duan, Xiangliang Yuan
Despite the popular use of dietary supplements during conventional cancer treatments, their impacts on the efficacies of prevalent immunotherapies, including immune-checkpoint therapy (ICT), are unknown. Surprisingly, our analyses of electronic healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbadfae3bf1ca3b84fe40c1ef2c54ec8
https://doi.org/10.1158/2159-8290.c.6549589.v1
https://doi.org/10.1158/2159-8290.c.6549589.v1
Autor:
Xiangliang Yuan, Yimin Duan, Yi Xiao, Kai Sun, Yutao Qi, Yuan Zhang, Zamal Ahmed, Davide Moiani, Jun Yao, Hongzhong Li, Lin Zhang, Arseniy E. Yuzhalin, Ping Li, Chenyu Zhang, Akosua Badu-Nkansah, Yohei Saito, Xianghua Liu, Wen-Ling Kuo, Haoqiang Ying, Shao-Cong Sun, Jenny C. Chang, John A. Tainer, Dihua Yu
Publikováno v:
Cancer Discov
Despite the popular use of dietary supplements during conventional cancer treatments, their impacts on the efficacies of prevalent immunotherapies, including immune-checkpoint therapy (ICT), are unknown. Surprisingly, our analyses of electronic healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5985879b0d56272b3b7831d3f94d5c50
https://doi.org/10.1158/2159-8290.cd-21-0900
https://doi.org/10.1158/2159-8290.cd-21-0900
Publikováno v:
Cancer Research. 83:5077-5077
Brain metastases (BrMs) represent an unmet challenge for the therapy of most aggressive cancers owing to the extremely poor survival and the limited efficacy of available therapies. Currently, NO curative therapy for breast cancer BrM (BCBrM) is avai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c44c74ab6a4c8fbf1e2172bf6f631990
https://doi.org/10.1158/1538-7445.am2023-5077
https://doi.org/10.1158/1538-7445.am2023-5077
Publikováno v:
Cancer Research. 83:673-673
Major neoplastic diseases have high incidences of brain metastasis (BrM) which is a clinically dreadful consequence of advanced cancers with an abysmal prognosis. Unfortunately, our understanding of the biology and molecular mechanisms underlying BrM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24b93e9cd7d1723f52ca596dc566fb66
https://doi.org/10.1158/1538-7445.am2023-673
https://doi.org/10.1158/1538-7445.am2023-673
Publikováno v:
Cancer Research. 83:6427-6427
Brain metastasis (BrM) incidence is rising due to longer survival resulted from better systemic control of cancer, counting for approximately 20% of patients with cancers. Major cancer types, including lung, breast, and skin cancers, have a high rate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e799e0fa61857691e7dab064dbefa5f
https://doi.org/10.1158/1538-7445.am2023-6427
https://doi.org/10.1158/1538-7445.am2023-6427
Autor:
Shao-Ping Yang, Yimin Duan, Xiangliang Yuan, Lin Zhang, Patrick Zhang, Jason T. Huse, Dihua Yu
Publikováno v:
Cancer Research. 82:4176-4176
Brain metastasis (BrM) affects millions of cancer patients and major cancer types, e.g., lung cancer, melanoma, and breast cancer, have high incidences of BrM. Symptomatic BrM patients have a less than 20% 1-year survival rate. The poor clinical outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d2907222589919230e56b50356d7bd1
https://doi.org/10.1158/1538-7445.am2022-4176
https://doi.org/10.1158/1538-7445.am2022-4176
Publikováno v:
Cancer Research. 82:6370-6370
Among the 300,000 newly diagnosed breast cancer patients every year, 5~20% of them will develop symptomatic brain metastasis, whose 1-year survival rate is lower than 20%. Our group previously reported that brain tumor microenvironment (TME)-mediated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee9e2bd5c99600f61bbf20575f2aa8c9
https://doi.org/10.1158/1538-7445.am2022-6370
https://doi.org/10.1158/1538-7445.am2022-6370